Co-Authors
This is a "connection" page, showing publications co-authored by Claudia Denkinger and Carsten Müller-Tidow.
Connection Strength
0.285
-
A Randomized Open label Phase-II Clinical Trial with or without Infusion of Plasma from Subjects after Convalescence of SARS-CoV-2 Infection in High-Risk Patients with Confirmed Severe SARS-CoV-2 Disease (RECOVER): A structured summary of a study protocol for a randomised controlled trial. Trials. 2020 Oct 06; 21(1):828.
Score: 0.227
-
Lack of antibodies against seasonal coronavirus OC43 nucleocapsid protein identifies patients at risk of critical COVID-19. J Clin Virol. 2021 06; 139:104847.
Score: 0.059